Sylvie Négrier Selected Research

Sylvie Négrier Research Topics

Disease

27	Renal Cell Carcinoma (Grawitz Tumor) 10/2021 - 12/2002
14	Neoplasms (Cancer) 06/2021 - 12/2005
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 09/2008
4	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2002
4	Disease Progression 11/2018 - 08/2008
3	Melanoma (Melanoma, Malignant) 01/2020 - 12/2005
3	Brain Neoplasms (Brain Tumor) 10/2019 - 02/2014
2	Carcinoma (Carcinomatosis) 06/2021 - 09/2003
2	Fatigue 06/2014 - 05/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2010 - 03/2003
1	Papillary Carcinoma 06/2021
1	Neurologic Manifestations (Neurological Manifestations) 11/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Pathologic Neovascularization 06/2014
1	Diarrhea 05/2014
1	Renal Insufficiency (Renal Failure) 01/2011
1	Proteinuria 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Thrombotic Microangiopathies 01/2011
1	Adenocarcinoma 06/2010
1	Tachycardia (Tachyarrhythmias) 11/2008
1	Hypotension (Low Blood Pressure) 11/2008
1	Neuroblastoma 10/2005
1	Neutropenia 03/2003
1	Febrile Neutropenia 03/2003
1	Colorectal Neoplasms (Colorectal Cancer) 12/2002

Drug/Important Bio-Agent (IBA)

9	Sunitinib (Sutent)FDA Link 01/2018 - 08/2008
8	Bevacizumab (Avastin)FDA Link 01/2018 - 05/2010
6	Tyrosine Kinase InhibitorsIBA 11/2018 - 01/2006
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2018 - 07/2011
5	Interferon-alpha (Interferon Alfa)IBA 01/2014 - 12/2002
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 01/2011
4	InterferonsIBA 06/2014 - 12/2002
4	Interleukin-2 (IL2)IBA 11/2008 - 12/2002
3	NivolumabIBA 01/2021 - 11/2018
3	pazopanib FDA Link 08/2017 - 05/2014
3	Irinotecan (Camptosar)FDA LinkGeneric 06/2010 - 03/2003
2	Monoclonal AntibodiesIBA 08/2017 - 06/2014
2	Pharmaceutical PreparationsIBA 02/2016 - 08/2008
2	temsirolimus FDA Link 10/2015 - 07/2011
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 10/2005
2	Gemcitabine FDA Link 09/2003 - 03/2003
1	Fumarate Hydratase (Fumarase)IBA 06/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	B7-H1 AntigenIBA 11/2018
1	cabozantinibIBA 11/2018
1	Axitinib (AG 013736)IBA 04/2018
1	Hormones (Hormone)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	cadherin 5IBA 01/2018
1	AlbuminsIBA 02/2016
1	MTOR InhibitorsIBA 10/2015
1	Dihydrotachysterol (AT 10)IBA 03/2015
1	Vascular Endothelial Growth Factor CIBA 01/2014
1	InterleukinsIBA 01/2014
1	Sorafenib (BAY 43-9006)FDA Link 09/2011
1	Radiation-Sensitizing AgentsIBA 06/2010
1	Interferon alpha-2 (Roferon-A)FDA Link 05/2010
1	shark cartilage extractIBA 11/2007
1	AntigensIBA 12/2005
1	Peptides (Polypeptides)IBA 12/2005
1	VaccinesIBA 12/2005
1	HLA-A1 Antigen (HLA A1 Antigen)IBA 12/2005
1	Cisplatin (Platino)FDA LinkGeneric 09/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2003
1	Docetaxel (Taxotere)FDA Link 03/2003

Therapy/Procedure

12	Therapeutics 10/2019 - 01/2006
4	Radiotherapy 11/2018 - 06/2010
3	Drug Therapy (Chemotherapy) 09/2003 - 12/2002
2	Proton Therapy 01/2020 - 03/2015
2	Molecular Targeted Therapy 06/2016 - 01/2011
2	Immunotherapy 11/2007 - 01/2006
1	Combined Modality Therapy 01/2020
1	Nephrectomy 11/2018
1	Biological Therapy 01/2018
1	Brachytherapy 03/2015
1	Duration of Therapy 01/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2008
1	Lasers (Laser) 10/2005
1	Cryotherapy (Therapy, Cold) 12/2002
1	Neoadjuvant Therapy 12/2002